Bharat Biotech expects WHO’s approval for Covaxin’s emergency use by July-September
Bharat Biotech, the manufacturing pharma company of Covaxin, is expecting to receive the World Health Organization’s (WHO) regulatory approval by the end of September. On Tuesday, Bharat Biotech declared that it has applied to WHO-Geneva for Emergency Use Listing (EUL) of Covaxin and further revealed the approval is anticipated by July-September 2021. Covishield, the vaccine…